[HTML][HTML] Effectiveness and safety of toripalimab, camrelizumab, and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients
J Chen, X Hu, Q Li, W Dai, X Cheng… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background The clinical significance of programmed cell death protein-1 (PD-1)-targeted
immunotherapy in Chinese patients is understudied. We thus aimed to evaluate the safety …
immunotherapy in Chinese patients is understudied. We thus aimed to evaluate the safety …
High-molecular-weight Fractions of Spruce and Eucalyptus Lignin as a perspective nanoparticle-based Platform for a therapy Delivery in liver cancer
IV Pylypchuk, H Suo… - … in Bioengineering and …, 2022 - frontiersin.org
The natural polymer, lignin, possesses unique biodegradable and biocompatible properties,
making it highly attractive for the generation of nanoparticles for targeted cancer therapy. In …
making it highly attractive for the generation of nanoparticles for targeted cancer therapy. In …
[HTML][HTML] Gadoxetic acid-enhanced MRI radiomics signature: Prediction of clinical outcome in hepatocellular carcinoma after surgical resection
Z Zhang, J Chen, H Jiang, Y Wei, X Zhang… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background This study aimed to evaluate the efficiency of gadoxetic acid-enhanced MRI-
based radiomics features for prediction of overall survival (OS) in hepatocellular carcinoma …
based radiomics features for prediction of overall survival (OS) in hepatocellular carcinoma …
[HTML][HTML] Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression
Q Li, B Ren, Q Gui, J Zhao, M Wu, M Shen… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Hepatocellular carcinoma (HCC) is the fourth most common malignant tumor in
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC …
[HTML][HTML] Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single …
Y Zhang, J Wang, H Li, T Zheng, H Jiang… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background The Liver Imaging Reporting and Data System treatment response algorithm (LI-
RADS TRA) was developed to evaluate the tumor response of patients with hepatocellular …
RADS TRA) was developed to evaluate the tumor response of patients with hepatocellular …
[HTML][HTML] Clinical management of vascular lake during transarterial chemoembolization with CalliSpheres drug-eluting beads (DEBs) for the treatment of hepatocellular …
J Kong, X Jiang, Y Zhang, W Wang, Y Li… - Translational Cancer …, 2020 - ncbi.nlm.nih.gov
Background To summarize the incidence and management strategy of vascular lake (VL)
during the treatment of hepatocellular carcinoma (HCC) using transarterial …
during the treatment of hepatocellular carcinoma (HCC) using transarterial …
程序性细胞死亡受体-1 抑制剂治疗中晚期非病毒性相关肝癌的效果及安全性分析.
刘浩楠， 王玉芹， 吴萌， 陆通， 赵阳… - Journal of Clinical …, 2022 - search.ebscohost.com
目的研究国产程序性细胞死亡受体r1 (PD r1) 抑制剂在中晚期非病毒性相关肝癌(nBnC r HCC)
中的临床疗效及不良反应. 方法选取2019 年6 月—2022 年2 月徐州医科大学附属医院收治的 …
中的临床疗效及不良反应. 方法选取2019 年6 月—2022 年2 月徐州医科大学附属医院收治的 …
[HTML][HTML] The overexpression of miRNA-212-5p inhibited the malignant proliferation of liver cancer cells HepG2 and the tumor formation in nude mice with transplanted …
R Han, Y Li, W Cao - Translational Cancer Research, 2020 - ncbi.nlm.nih.gov
Background This study aims to investigate the effect of miR-212-5p overexpression targeting
suppressor of cytokine signaling 5 (SOCS5) on the malignant proliferation of liver cancer …
suppressor of cytokine signaling 5 (SOCS5) on the malignant proliferation of liver cancer …
[HTML][HTML] Protein tyrosine phosphatase receptor type delta (PTPRD) suppresses the expression of PD-L1 in human hepatocellular carcinoma by down-regulating …
Q Meng, J Tian, F Qin, X Huang, D Zhu… - Translational Cancer …, 2020 - ncbi.nlm.nih.gov
Background Protein tyrosine phosphatase receptor type delta (PTPRD) is a tumor
suppressor that is often inactivated in hepatocellular carcinoma (HCC). However, the …
suppressor that is often inactivated in hepatocellular carcinoma (HCC). However, the …
Effectiveness and safety of programmed cell death-1 inhibitor in the treatment of advanced non-HBV non-HCV-related hepatocellular carcinoma
LIU Haonan, WU Meng, LU Tong, HAN Zhengxiang - 临床肝胆病杂志, 2022 - lcgdbzz.org
Objective To investigate the clinical effectiveness and adverse events of domestic
programmed cell death-1 (PD-1) inhibitor in the treatment of advanced non-HBV non-HCV …
programmed cell death-1 (PD-1) inhibitor in the treatment of advanced non-HBV non-HCV …